Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.07.20.739706

Diversity at the Acinetobacter baumannii K locus: towards a comprehensive in silico database for prediction of capsular polysaccharide types

Abstract

Acinetobacter baumannii is one of the most critical bacterial pathogens requiring novel approaches for infection control and treatment to curb the spread of highly resistant isolates. Epidemiological surveillance, and the design and application of many non-antibiotic interventions, require rapid and accurate prediction of diverse capsular polysaccharide (CPS) types from whole genome sequence data. The internationally adopted CPS typing system relies on the in-silico detection of CPS biosynthesis genes both in and outside the K locus (KL), utilising a reference sequence database that is compatible with the bioinformatics tool, Kaptive. In this study, 168 novel loci were added to the database following an extensive survey of publicly available A. baumannii genomes and non-redundant sequence entries, bringing the total number of reference sequences to 409 KL and 10 extra-locus genes. All novel loci conformed to the characteristic K locus configuration described previously, with conserved core genes for CPS biosynthesis flanking a central and highly variable region that includes type-specific structural genes. Across the 409 KL, there were 1000 protein clusters. Annotations for 309 novel clusters were curated and validated using a variety of sequence-and structure-based approaches. Most proteins (n=781) were encoded by genes found in [≤]4 KL, consistent with extensive structural diversity of CPS types in A. baumannii as reported previously. However, gene distribution analysis predicted shared structural features, with several KL predicting the same CPS type or K unit. Validation of the updated database against 46,185 publicly available genomes revealed that 32 K loci were present in 87.1% of sequenced isolates, with an overrepresentation of genomes with KL2, KL3, KL18, KL9 or KL22. IMPACT STATEMENTCapsular polysaccharide (CPS) typing is embedded in in-silico genomic approaches utilised for characterisation and epidemiological surveillance of Acinetobacter baumannii isolates. As new information regarding CPS diversity and structures becomes available, continual updates to the integrated typing database are essential to ensure accuracy and endurance as a valuable scientific resource. The rapid expansion of genome data released into public databases, particularly from previously underrepresented geographies and isolation sources in recent years, provided an opportunity to capture further diversity in CPS encoding regions to enhance the utility of the typing database. A total of 168 novel K loci were identified and added to the database, and an analysis of gene distribution across all 409 loci predicted shared CPS features. This work is expected to enhance KL typing and prediction of CPS structural features for studies involving diagnostics, surveillance and therapeutics applications. DATA AVAILABILITYAll genome sequences used in this study are publicly available with details and accession numbers listed in Supplementary Table 1. The updated database with 409 KL and 10 extra-locus reference sequences is freely available at https://github.com/johannajkenyon/Abaumannii_surface_polysaccharide_loci.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Kenyon, J. J.. 2026-07-21. Diversity at the Acinetobacter baumannii K locus: towards a comprehensive in silico database for prediction of capsular polysaccharide types. https://doi.org/10.64898/2026.07.20.739706

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

pTRIP, a novel integration plasmid for Listeria monocytogenes

In the past decades, several tools to genetically modify the human pathogen Listeria monocytogenes were developed. Here, we constructed a new integrative plasmid system for L. monocytogenes named pTRIP, for treB insertion plasmid. pTRIP is a vector which stably integrates into the treB locus of the wild type EGD-e. This locus encodes the sole trehalose-specific EIIB and EIIC component of a phosphotransferase system. Successful integration leads to the disruption of treB and thus, to an inability of the resulting L. monocytogenes strains to grow on trehalose as sole carbon source. Due to integration through double homologous recombination, it is the first integrative system which does not require antibiotic selection pressure. To assess functionality of the pTRIP system, prfA and its native promoter region were integrated into the treB locus of a {Delta}prfA strain. Complementation was confirmed in 78% of the isolated clones, indicating successful integration of prfA into the treB locus. We further constructed derivatives of pTRIP harboring the constitutive Pp60 (pTRIP1) and the inducible Prha (pTRIP2) promoter to further expand application possibilities. Microscopic analyses confirmed the functionality of both promoter constructs and showed dose-dependent induction for Prha. pTRIP is an efficient tool for stable gene expression as well as functional studies and expands genetic modification possibilities for L. monocytogenes.

microbiology↗

A rational design strategy and validation for protease-resistant fusion-inhibitor antiviral peptides

Peptide-based fusion inhibitors are promising pharmaceuticals in the fight against enveloped viruses relying on membrane fusion for host infection. However, peptide therapeutic applications have long been hindered by their poor stability in vivo. Here, we discovered that peptide inhibitors with the wildtype sequence of the heptad repeat 2 (HR2) domain of the SARS-CoV-2 spike protein are efficiently cleaved by Transmembrane Protease, Serine 2 (TMPRSS2), a key protease involved in the SARS-CoV-2 virus-cell fusion pathway. We then identified the corresponding cleavage sites and designed three protease-resistant peptides using ranking based on deep mutational scanning and natural occurrence. The three candidates all exhibit inhibitory activity in a cell-cell fusion assay. A high-resolution cryo-EM structure of the top candidate, HR2-NHN, bound to its HR1 target reveals the molecular basis for its potent activity. The top candidate of the cell-based screening assay significantly improved efficacy relative to the wildtype peptide when administered 12 h before infection in both an authentic virus-cell infection assay and a mouse assay. More broadly, our results suggest that the design strategies for protease-resistant peptides could be applied to a broad spectrum of other enveloped viruses and pave the way for the development of safe, prophylactic antivirals that can be administered before exposure.

microbiology↗

Host soluble inositol phosphate signaling promotes coronavirus replication

Coronaviruses rely extensively on host pathways for replication, making host-directed therapies an attractive strategy for broad-spectrum antivirals with reduced risk of viral resistance. Here we identify the host soluble inositol phosphate pathway as a previously unrecognized dependency for coronavirus infection. Genetic or pharmacologic inhibition of several kinases in this pathway markedly suppresses replication of both alpha- and betacoronaviruses, while increasing pathway activity promotes viral replication. We developed UNC7844, a potent multi-target inhibitor of these kinases, which reduces coronavirus replication by more than four orders of magnitude in cultured cells and suppresses coronavirus infection in mice. Mechanistically, UNC7844 suppresses inositol (pyro)phosphates production, disrupts phosphoinositide homeostasis, and impairs late endosomal dynamics, blocking early post-entry steps required for viral genome release and replication. Together, our findings establish the soluble inositol (pyro)phosphate pathway as an important regulator of coronavirus infection and highlight its inhibition as a promising host-directed antiviral strategy.

microbiology↗